Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | GLP2R | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Glp2r (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GLP2R mRNA | CTD | PMID:36331819 | GLP2R | Human | 1,2-dichloroethane | decreases expression | ISO | Glp2r (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of GLP2R mRNA | CTD | PMID:28960355 | GLP2R | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Glp2r (Rattus norvegicus) | 6480464 | [APC protein affects the susceptibility to 1 and 2-Dimethylhydrazine] which results in decreased expression of GLP2R mRNA | CTD | PMID:27840820 | GLP2R | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Glp2r (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of GLP2R mRNA] | CTD | PMID:22206623 | GLP2R | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Glp2r (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of GLP2R mRNA | CTD | PMID:22206623 | GLP2R | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GLP2R mRNA | CTD | PMID:28628672 | GLP2R | Human | ammonium chloride | affects expression | ISO | Glp2r (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of GLP2R mRNA | CTD | PMID:16483693 | GLP2R | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of GLP2R mRNA | CTD | PMID:32234424 | GLP2R | Human | bisphenol A | affects expression | ISO | Glp2r (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of GLP2R mRNA | CTD | PMID:25181051 | GLP2R | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GLP2R mRNA | CTD | PMID:28628672 | GLP2R | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to GLP2R gene] | CTD | PMID:28238834 | GLP2R | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of GLP2R mRNA | CTD | PMID:27392435 | GLP2R | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of GLP2R mRNA | CTD | PMID:27392435 | GLP2R | Human | cocaine | decreases expression | ISO | Glp2r (Rattus norvegicus) | 6480464 | Cocaine results in decreased expression of GLP2R mRNA | CTD | PMID:17898221 | GLP2R | Human | crocidolite asbestos | increases expression | ISO | Glp2r (Mus musculus) | 6480464 | Asbestos and Crocidolite results in increased expression of GLP2R mRNA | CTD | PMID:29279043 | GLP2R | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GLP2R mRNA | CTD | PMID:28628672 | GLP2R | Human | doxorubicin | increases expression | ISO | Glp2r (Mus musculus) | 6480464 | Doxorubicin results in increased expression of GLP2R mRNA | CTD | PMID:36227756 | GLP2R | Human | folic acid | multiple interactions | ISO | Glp2r (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of GLP2R mRNA] | CTD | PMID:22206623 | GLP2R | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GLP2R mRNA | CTD | PMID:28628672 | GLP2R | Human | methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of GLP2R mRNA | CTD | PMID:24449571 | GLP2R | Human | nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of GLP2R mRNA | CTD | PMID:22714537 | GLP2R | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of GLP2R mRNA | CTD | PMID:26690555 | GLP2R | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Glp2r (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GLP2R mRNA | CTD | PMID:36331819 | GLP2R | Human | perfluorooctanoic acid | increases expression | ISO | Glp2r (Rattus norvegicus) | 6480464 | perfluorooctanoic acid results in increased expression of GLP2R mRNA | CTD | PMID:28511854 | GLP2R | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of GLP2R mRNA | CTD | PMID:25895662 | GLP2R | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of GLP2R mRNA | CTD | PMID:38568856 | GLP2R | Human | titanium dioxide | increases expression | ISO | Glp2r (Mus musculus) | 6480464 | titanium dioxide results in increased expression of GLP2R mRNA | CTD | PMID:35295148 | GLP2R | Human | trovafloxacin | increases expression | ISO | Glp2r (Mus musculus) | 6480464 | trovafloxacin results in increased expression of GLP2R mRNA | CTD | PMID:35537566 | |